Dual-color Imaging of HER2 and HER3 Interaction
Corresponding Organization :
Other organizations : The Francis Crick Institute, AstraZeneca (United Kingdom), King's College London, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Research Complex at Harwell
Variable analysis
- Treatment with 30 μM AC3573 compound or 0.3% DMSO
- HER2-Alexa488 Affibody and HER3-CF640R Affibody or NRG-CF640R binding
- Colocalization and τON (ON-time) of HER2 and HER3
- CHO cells plated at 1.8 × 10^5 cells/dish on 1% BSA-coated 35 mm glass-bottom dishes
- Cells grown for 24 h before transfection with HA-HER2-WT and HA-HER3-WT full-length plasmids using Viafect
- Cells serum-starved for 1 h before treatment
- Imaging using an Axiovert 200M microscope with TIRF illuminator, 100× oil-immersion objective, and EMCCD camera
- Illumination using 488 nm and 642 nm laser lines, and Optosplit Image Splitter to separate spectral components
- Field of view of 80 × 30 μm for single-molecule imaging
- Data analyzed using multidimensional analysis software
- None specified
- 0.3% DMSO treatment
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!